PMID: 8978734Jan 1, 1997Paper

Amyloid beta protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals

Journal of Neurochemistry
K UedaK Kawasaki

Abstract

Amyloid beta protein (A beta), the central constituent of senile plaques in Alzheimer's disease (AD) brain, is known to exert toxic effects on cultured neurons. The role of the voltage-sensitive Ca2+ channel (VSCC) in beta (25-35) neurotoxicity was examined using rat cultured cortical and hippocampal neurons. When L-type VSCCs were blocked by application of nimodipine, beta (25-35) neurotoxicity was attenuated, whereas application of omega-conotoxin GVIA (omega-CgTX-GVIA) or omega-agatoxin IVA (omega-Aga-IVA), the blocker for N- or P/Q-type VSCCs, had no effects. Whole-cell patch-clamp studies indicated that the Ca2+ current density of beta (25-35)-treated neurons is about twofold higher than that of control neurons. Also, beta (25-35) increased Ca2+ uptake, which was sensitive to nimodipine. The 2', 7'-dichlorofluorescin diacetate assay showed the ability of beta (25-35) to produce reactive oxygen species. Nimodipine had no effect on the level of free radicals. In contrast, vitamin E, a radical scavenger, reduced the level of free radicals, neurotoxicity, and Ca2+ uptake. These results suggest that beta (25-35) generates free radicals, which in turn, increase Ca2+ influx via the L-type VSCC, thereby inducing neurotoxicity.

Citations

Aug 3, 2001·Nature Reviews. Neuroscience·D H SmallJ C Bornstein
Jul 20, 2001·Journal of Neurochemistry·P I HoT B Shea
Dec 26, 2001·Molecular Pharmacology·Tatsurou YagamiYozo Hori
Jun 18, 2002·Journal of Neurochemistry·Tatsurou YagamiYozo Hori
Jun 26, 2003·Journal of Biomedical Science·Yen-Jen SungHuey-Jen Tsay
Jul 2, 2003·Journal of Neuroscience Research·Gema AlvarezElena Bogónez
Apr 7, 2007·Annals of the New York Academy of Sciences·Blaine E BiselKaren D Parfitt
Aug 5, 2009·Journal of Cellular and Molecular Medicine·Kim N Green
Nov 26, 2009·Journal of Cellular and Molecular Medicine·Marina HermesOlga Garaschuk
Sep 4, 2015·Molecular Neurobiology·Tatsurou YagamiYasuhiro Yamamoto
May 4, 2016·Cellular and Molecular Neurobiology·Daniel C Moreira-LoboFernando A Oliveira
Jan 1, 2017·Neurochemical Research·Andrzej SzutowiczJoanna Klimaszewska-Łata
Feb 2, 2020·Molecular Neurobiology·Yasuhiro YamamotoTatsurou Yagami
Jul 29, 2003·Aging Cell·Tamara R GoldenSimon Melov
Dec 10, 1998·Journal of Biomedical Science·A Y Sun, Y M Chen
Jun 29, 2001·Journal of Peptide Science : an Official Publication of the European Peptide Society·A B ClippingdaleC J Barrow
Jan 15, 2005·Antioxidants & Redox Signaling·Robert G Salomon
Dec 16, 2006·Journal of Neuroscience Research·Julio Santos-TorresJavier Yajeya
Jul 25, 2009·Antioxidants & Redox Signaling·Rao Muralikrishna Adibhatla, James Franklin Hatcher
Oct 1, 2010·Reviews in the Neurosciences·Susana Ferrao SantosJean-Noël Octave
Sep 12, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Seung-Young HongMira Jun
Sep 25, 2015·Journal of Alzheimer's Disease : JAD·Virginie GilsonJean de Barry
Oct 22, 2016·Journal of Alzheimer's Disease : JAD·Qian Cai, Prasad Tammineni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.